Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1300 of 2400 entries
View as:

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

Phase: N/A Priority: Normal
NCT ID: NCT00000721 Org: User:
Start: - End: 03/31/91 Due: 03/31/92

A "Pre-Enrollment" Protocol for HIV-Infected Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00000780 Org: User:
Start: - End: - Due: -

A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Phase: N/A Priority: Normal
NCT ID: NCT00000922 Org: User:
Start: - End: 06/30/06 Due: 06/30/07

A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00000868 Org: User:
Start: - End: 05/31/00 Due: 05/31/01

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00000847 Org: User:
Start: - End: 05/31/99 Due: 05/31/00

A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.

Phase: N/A Priority: Normal
NCT ID: NCT00000856 Org: User:
Start: - End: - Due: -

A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells

Phase: N/A Priority: Normal
NCT ID: NCT00000667 Org: User:
Start: - End: 07/31/93 Due: 07/31/94

A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols

Phase: N/A Priority: Normal
NCT ID: NCT00000784 Org: User:
Start: 10/31/94 End: 09/30/96 Due: 09/30/97

A Study of Azidothymidine in HIV-Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT00000982 Org: User:
Start: - End: - Due: -

The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000817 Org: User:
Start: 11/30/94 End: 05/31/97 Due: 05/31/98

A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00000715 Org: User:
Start: - End: 09/30/91 Due: 09/30/92

Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia

Phase: N/A Priority: Normal
NCT ID: NCT00000705 Org: User:
Start: - End: 03/31/89 Due: 03/31/90

A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00000996 Org: User:
Start: - End: 06/30/90 Due: 06/30/91

The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00000825 Org: User:
Start: 05/31/98 End: - Due: -

Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks

Phase: N/A Priority: Normal
NCT ID: NCT00000670 Org: User:
Start: - End: 07/31/89 Due: 07/31/90

A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00000754 Org: User:
Start: - End: 02/28/95 Due: 02/28/96

An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex

Phase: N/A Priority: Normal
NCT ID: NCT00000672 Org: User:
Start: - End: - Due: -

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

Phase: N/A Priority: Normal
NCT ID: NCT00000891 Org: User:
Start: - End: 05/31/04 Due: 05/31/05

An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000647 Org: User:
Start: - End: 12/31/94 Due: 12/31/95

Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants

Phase: N/A Priority: Normal
NCT ID: NCT00000917 Org: User:
Start: 09/30/97 End: - Due: -

A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons

Phase: N/A Priority: Normal
NCT ID: NCT00000743 Org: User:
Start: - End: 05/31/95 Due: 05/31/96

The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00000990 Org: User:
Start: - End: 09/30/92 Due: 09/30/93

A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00000737 Org: User:
Start: - End: - Due: -

Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children

Phase: N/A Priority: Normal
NCT ID: NCT00000773 Org: User:
Start: - End: 09/30/96 Due: 09/30/97

Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.

Phase: N/A Priority: Normal
NCT ID: NCT00000818 Org: User:
Start: - End: - Due: -